Rx Risk Descriptions Need To Be Standardized, FDA’s Galson Tells CERTs

The standardization of risk expressions to compare drugs would be a desirable risk management tool, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, suggested at a recent CERTs meeting